Quarterly report pursuant to Section 13 or 15(d)

Basis of presentation, summary of significant accounting policies and recent accounting pronouncements (Tables)

v3.19.1
Basis of presentation, summary of significant accounting policies and recent accounting pronouncements (Tables)
3 Months Ended
Mar. 31, 2019
Accounting Policies [Abstract]  
Schedule of Antidilutive Securities
Securities that could potentially dilute loss per share in the future that were not included in the computation of diluted loss per share at March 31, 2019 and 2018 because their inclusion would be anti-dilutive are as follows:
 
 
 
March 31,
 
 
 
2019
   
2018
 
Warrants to purchase common stock
   
3,579,257
     
1,831,886
 
Options to purchase common stock
   
62,000
     
150,000
 
Unvested restricted stock awards
   
33,542
     
681,176
 
Escrow shares of common stock
   
200,000
     
200,000
 
Convertible Series B preferred shares
   
13,000
     
928,000
 
Convertible notes
   
1,813,500
     
-
 
Total
   
5,701,299
     
3,791,062